Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma
Authors:
- Jiawen YangJYJiawen Yang
- Paul VictorPVPaul Victor
- Marcelo G. CoronaMCMarcelo G. Corona
- Qiong PanQPQiong Pan
- Gillian D. Paine-MurrietaGPGillian D. Paine-Murrieta
- James A. DeCaprioJDJames A. DeCaprio
Preprint
Abstract
Merkel Cell Carcinoma (MCC) is an aggressive neuroendocrine cutaneous malignancy arising from either ultraviolet-induced mutagenesis or Merkel cell polyomavirus (MCPyV) integration. Despite extensive research, our understanding of the molecular mechanisms driving the transition from normal cells to MCC remains limited. To address this knowledge gap, we assessed the impact of inducible MCPyV T antigens on normal human fibroblasts by performing RNA sequencing. Our data uncovered changes in expression and regulation of Wnt signaling pathway members. Building on this observation, we bioinformatically evaluated various Wnt pathway perturbagens for their ability to reverse the MCC gene expression signature and identified pyrvinium pamoate, an FDA-approved anthelminthic drug known for its anti-tumor activity in other cancers. Leveraging transcriptomic, network, and molecular analyses, we found that pyrvinium targets multiple MCC vulnerabilities. Pyrvinium not only reverses the neuroendocrine features of MCC by modulating canonical and non-canonical Wnt signaling but also inhibits cancer cell growth by activating p53-mediated apoptosis, disrupting mitochondrial function, and inducing endoplasmic reticulum stress. Finally, we demonstrated that pyrvinium reduces tumor growth in an MCC mouse xenograft model. These findings offer a new understanding of the role of Wnt signaling in MCC and highlight the utility of pyrvinium as a potential treatment for MCC.Keywords
All Related Versions
- Published version: Journal of Clinical Investigation, 135 (7).
This publication has 70 references indexed in Scilit:
- Inhibition of T-antigen expression promoting glycogen synthase kinase 3 impairs merkel cell carcinoma cell growthCancer Letters, 2022
- Identification of the FDA‐Approved Drug Pyrvinium as a Small‐Molecule Inhibitor of the PD‐1/PD‐L1 InteractionChemMedChem, 2021
- Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillanceCancer Medicine, 2019
- Wnt5a promotes differentiation and development of adult-born neurons in the hippocampus by noncanonical Wnt signalingStem Cells, 2019
- Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinomaCancer Medicine, 2016
- Hotspot mutations in polyomavirus positive and negative Merkel cell carcinomasCancer Genetics, 2015
- Alternative Wnt Signaling Activates YAP/TAZCell, 2015
- The impact of pyrvinium pamoate on colon cancer cell viabilityInternational Journal of Colorectal Disease, 2014
- Lack of Wnt5A Expression in Merkel Cell CarcinomaArchives of Dermatology, 2010
- Wnt genesCell, 1992